NCT05630339View on ClinicalTrials.gov

Magnesium and Vitamin D Combination for Post-COVID Syndrome

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 30, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

September 1, 2023

Conditions
Post-COVID-19 SyndromeLong COVIDVitamin D DeficiencyMagnesium Deficiency
Interventions
DIETARY_SUPPLEMENT

Magnesium chloride

Each 650 mg capsule contains 340 mg of magnesium chloride, which must be ingested twice a day with aliments.

DIETARY_SUPPLEMENT

Vitamin D

Each tablet contains 4000 IU of vitamin D, and must be ingested a pill per night.

DIETARY_SUPPLEMENT

Inert placebo

Instead of dietary supplements, sodium bicarbonate as inert placebo will be administered twice a day in 650 mg capsules.

Trial Locations (1)

34067

Biomedical Research Unit. IMSS. Durango, Durango

All Listed Sponsors
collaborator

Consejo de Ciencia y Tecnología del Estado de Durango

UNKNOWN

lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV